These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8063233)

  • 1. Prospective multicenter study on CA 125 in postmenopausal pelvic masses.
    Maggino T; Gadducci A; D'Addario V; Pecorelli S; Lissoni A; Stella M; Romagnolo C; Federghini M; Zucca S; Trio D
    Gynecol Oncol; 1994 Aug; 54(2):117-23. PubMed ID: 8063233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of probability of malignancy using a logistic model combining physical examination, ultrasound, serum CA 125, and serum CA 72-4 in postmenopausal women with a pelvic mass: an international multicenter study.
    Schutter EM; Sohn C; Kristen P; Möbus V; Crombach G; Kaufmann M; Caffier H; Kreienberg R; Verstraeten AA; Kenemans P
    Gynecol Oncol; 1998 Apr; 69(1):56-63. PubMed ID: 9570999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of pelvic examination, ultrasound, and serum CA 125 in postmenopausal women with a pelvic mass. An international multicenter study.
    Schutter EM; Kenemans P; Sohn C; Kristen P; Crombach G; Westermann R; Môbus V; Kaufmann M; Caffier H; Schmidt-Rhode P
    Cancer; 1994 Aug; 74(4):1398-406. PubMed ID: 8055463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CA 125 in the diagnosis of pelvic masses.
    Mogensen O; Mogensen B; Jakobsen A
    Eur J Cancer Clin Oncol; 1989 Aug; 25(8):1187-90. PubMed ID: 2767108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative serum tumor-associated antigen levels in women with pelvic masses.
    Soper JT; Hunter VJ; Daly L; Tanner M; Creasman WT; Bast RC
    Obstet Gynecol; 1990 Feb; 75(2):249-54. PubMed ID: 2300353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility of CA 125 in preoperative diagnosis of patients with pelvic masses.
    Finkler NJ
    Eur J Obstet Gynecol Reprod Biol; 1993 Apr; 49(1-2):105-7. PubMed ID: 8365503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: discrimination of benign from malignant disease.
    Malkasian GD; Knapp RC; Lavin PT; Zurawski VR; Podratz KC; Stanhope CR; Mortel R; Berek JS; Bast RC; Ritts RE
    Am J Obstet Gynecol; 1988 Aug; 159(2):341-6. PubMed ID: 2457318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on angiogenesis in the benign and malignant ovarian neoplasms with the use of color and pulsed Doppler sonography and serum CA-125, CA-19.9, CA-72.4 and vascular endothelial growth factor measurements.
    Czekierdowski A
    Ann Univ Mariae Curie Sklodowska Med; 2002; 57(1):113-31. PubMed ID: 12898913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of transvaginal ultrasonography and serum CA 125 assay combined with age and hormonal state in the differential diagnosis of pelvic masses.
    Mancuso A; De Vivo A; Triolo O; Irato S
    Eur J Gynaecol Oncol; 2004; 25(2):207-10. PubMed ID: 15032283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of pelvic masses with transabdominal color Doppler, CA 125 and ultrasonography.
    Franchi M; Beretta P; Ghezzi F; Zanaboni F; Goddi A; Salvatore S
    Acta Obstet Gynecol Scand; 1995 Oct; 74(9):734-9. PubMed ID: 7572110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CA 125 in preoperative evaluation of pelvic masses.
    Pyrgiotis E; Salamalekis E; Loghis C; Dima C; Zourlas PA
    Eur J Gynaecol Oncol; 1993; 14(4):279-82. PubMed ID: 8344320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of malignancy index used as a diagnostic tool in a tertiary centre for patients with a pelvic mass.
    Håkansson F; Høgdall EV; Nedergaard L; Lundvall L; Engelholm SA; Pedersen AT; Hartwell D; Høgdall C;
    Acta Obstet Gynecol Scand; 2012 Apr; 91(4):496-502. PubMed ID: 22229703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-dimensional ultrasonography and power Doppler in ovarian cancer screening of asymptomatic peri- and postmenopausal women.
    Kurjak A; Prka M; Arenas JM; Sparac V; Merce LT; Corusic A; Ivancic-Kosuta M
    Croat Med J; 2005 Oct; 46(5):757-64. PubMed ID: 16158468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125.
    Van Calster B; Timmerman D; Bourne T; Testa AC; Van Holsbeke C; Domali E; Jurkovic D; Neven P; Van Huffel S; Valentin L
    J Natl Cancer Inst; 2007 Nov; 99(22):1706-14. PubMed ID: 18000221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of CA 125 for ovarian carcinoma in patients presenting with pelvic masses.
    O'Connell GJ; Ryan E; Murphy KJ; Prefontaine M
    Obstet Gynecol; 1987 Dec; 70(6):930-2. PubMed ID: 3479735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which extrauterine pelvic masses are difficult to correctly classify as benign or malignant on the basis of ultrasound findings and is there a way of making a correct diagnosis?
    Valentin L; Ameye L; Jurkovic D; Metzger U; Lécuru F; Van Huffel S; Timmerman D
    Ultrasound Obstet Gynecol; 2006 Apr; 27(4):438-44. PubMed ID: 16526098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of CA 125 levels in differentiating malignant from benign tumors in patients with pelvic masses.
    Chen DX; Schwartz PE; Li XG; Yang Z
    Obstet Gynecol; 1988 Jul; 72(1):23-7. PubMed ID: 3164105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined CA-125 test and ultrasonography in the presurgical evaluation of ovarian mass].
    Chiu SW; Ho SC; Hung YC; Lee YH
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1991 Aug; 7(8):429-34. PubMed ID: 1875465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reliability of IOTA score and ADNEX model in the screening of ovarian malignancy in postmenopausal women.
    Nohuz E; De Simone L; Chêne G
    J Gynecol Obstet Hum Reprod; 2019 Feb; 48(2):103-107. PubMed ID: 29709594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a multimarker assay for differential diagnosis of benign and malignant pelvic masses.
    Chen X; Zhou H; Chen R; He J; Wang Y; Huang L; Sun L; Duan C; Luo X; Yan H
    Clin Chim Acta; 2015 Feb; 440():57-63. PubMed ID: 25447698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.